Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-05 15:43:38 - browse：91

A DNA helix, with dollar banknotes covering its strands, collapses next to another DNA helix with dollar banknotes strands — coverage from STAT — Adobe

The closely watched gene-editing startup Prime Medicine is embroiled in a multimillion-dollar dispute with another biotech it partnered with to develop a potentially powerful new form of genome editing.

Prime and Myeloid Therapeutics, a startup co-founded by Pulitzer Prize-winning writer and cancer biologist Siddhartha Mukherjee, have filed competing arbitration claims over a deal they signed in March 2022.

Prime, spun out of the lab of Broad Institute biochemist David Liu, was built on technology for making small insertions, deletions, and single-letter changes in DNA. In theory, prime editing allows researchers to tackle the vast majority of disease-causing mutations, and the first treatments are already being readied for clinical trials. But it’s a poor fit in cases where hundreds or even thousands of different mutations in a long gene cause the same diseases, such as cystic fibrosis or Duchenne muscular dystrophy.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Eight reasons why you should get an updated Covid vaccine

hotspot

WSS

Abridge raises $150m as clinical notes automation market heats up

Eight reasons why you should get an updated Covid vaccine

How clinical AI models' predictive power can degrade over time

FDA warns medical device makers about rise in fabricated data

How should state employee insurance handle Wegovy?

Measles policy set amid Florida outbreak alarms vaccine proponents

hotspot

Wikipedia

hotspot

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Moonlake's readout produced a cash windfall. Risks remain

New CMS data security rules will hurt Medicare, Medicaid research

23andMe had bad news about my health. I wish a person had delivered it

Life sciences deals on track to hit lowest point since 2017

Peter Hotez and the public health issue of online harassment

WATCH: Why do our ears pop?

Medicare details structure of new drug price negotiation program

Akero's treatment for NASH falls short in cirrhosis study

focus

What's changing in Medicare's open enrollment this year?

MD Anderson's Padmanee Sharma responds to research credit suit

Better Therapeutics data on benefit with GLP

Readout LOUD podcast: Merger Mondays, Ozempic panic

Bernie Sanders bashes nonprofit hospitals over their tax breaks

MD Anderson's Padmanee Sharma responds to research credit suit

explore

hotspot

hotspot

hotspot